课题基金 / 基金详情

Study on patho-epidemiology of malignant lymphoma in Japan

Study on patho-epidemiology of malignant lymphoma in Japan
日本恶性淋巴瘤病理流行病学研究
批准号:
16390105
负责人:
AOZASA Katsuyuki
金额:
$6.85万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

AOZASA Katsuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study based on the cases with malignant lymphomas registered in the Osaka Lymphoma Study Group and the cases with pyothorax-associated lymphoma (PAL) and nasal NK/T-cell lymphoma (NKTCL). Malignant lymphomas developed in rheumatoid arthritis were also included. Epidemiological and molecular analysis were performed on these cases. The main findings obtained from these findings were as follows.1. Case-control study in Japan(5 institutes), Korea (Yonsei Univ), and China (China Medical Univ) revealed that pesticides and chemical solvents were risk factors for development of NKTCL (Int J Cancer 2006).2. PAL is an EBV-associated lymphoma. Loss of EBNA-2 one of EBV-coded latent genes, correlated with prognosis of PAL patients (Int J Cancer 2006).3. It is known that lymphoproliferative disease (LPD) develop relative frequently in patients with rheumatoid arthritis (RA), in which methotrexate (MTX) administration for RA is supposed to be involved. Then we compared the RA-LPD with and without MT X medication, showing no fundamental differences between them. (J Rheum 2007).4.Mutations of DNA mismatch repair genes, ATM, ATR, and MRE 11, in 50 cell lines from lymphoid leukemias and lymphomas, were examined. Mutations of ATM and MRE 11 were occasionally found. These mutations might cause genome instability, and finally result in lymphoid neoplasias. (Cancer Sci 2006).
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with Wilms' tumor gene WT1.
AML1-ETO 与 Wilms 肿瘤基因 WT1 协同作用,快速诱发急性髓细胞白血病。
DOI: --
发表时间: 2006
期刊: Blood 107
影响因子: --
作者: [Nishida S, Aozasa K, et al.]
通讯作者: et al.
DOI: 10.1002/ajh.20091
发表时间: 2004-07-01
期刊: AMERICAN JOURNAL OF HEMATOLOGY
影响因子: 12.8
作者: [Miyazato, H, Nakatsuka, S, Aozasa, K]
通讯作者: Aozasa, K
AMLI-ETO rapidly induces acute lymphoblastic leukemia in cooperation with Wilms' tumor gene WT1.
AMLI-ETO与Wilms肿瘤基因WT1配合快速诱发急性淋巴细胞白血病。
DOI: --
发表时间:
期刊: Blood (in press)
影响因子: --
作者: [Nishida S, Aozasa K, et al.]
通讯作者: et al.
Lymphopro liferative disorders in autoimmune disease in Japan : Analysis of clinico pathological features and EBV infection.
日本自身免疫性疾病中的淋巴细胞增殖性疾病:临床病理特征和 EBV 感染分析。
DOI: --
发表时间: 2004
期刊: Int J Cancer 108
影响因子: --
作者: [Hoshida Y, et al.]
通讯作者: et al.
24
    Patho-epidemiological study on the nasal NK/T cell lymphoma.
    • 批准号:
      15406013
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.53万
    • 财政年份:
      2003
    • 负责人:
      AOZASA Katsuyuki
    • 依托单位:
    Analysis of DNA sequence of immunoglobulin heavy chain variable region gene in lymphomas developing from chronic inflammation
    • 批准号:
      12670159
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.77万
    • 财政年份:
      2000
    • 负责人:
      AOZASA Katsuyuki
    • 依托单位:
    Pathological and epidemiologic study on nasal NK/T-cell lymphoma
    • 批准号:
      12576004
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.34万
    • 财政年份:
      2000
    • 负责人:
      AOZASA Katsuyuki
    • 依托单位:
    Study on modifying factors in the development of EBV-associated lymphomas
    • 批准号:
      09670184
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1997
    • 负责人:
      AOZASA Katsuyuki
    • 依托单位:
    国内基金
    海外基金
    胎盘异常与血管瘤形成关系的分子机制
    • 批准号:
      30872688
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2008
    • 负责人:
      张端莲
    • 依托单位:
    胶质瘤发生的分子病因研究
    • 批准号:
      30371457
    • 项目类别:
      面上项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2003
    • 负责人:
      黄强
    • 依托单位: